ZANOPRIMA LIFESCIENCES FILES PATENT INFRINGEMENT ACTION AGAINST HANGSEN INTERNATIONAL TO ENFORCE ITS GROUNDBREAKING ENZYMATIC PROCESS FOR SYNTHESIZING (S)-NICOTINE
WACO, Texas, March 30, 2022 /PRNewswire/ — On March 12, 2022, Zanoprima Lifesciences Ltd. (“Zanoprima”) filed a Complaint for Patent
Read More